domingo, 27 de mayo de 2018

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing | Breast Cancer | JAMA | JAMA Network

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing | Breast Cancer | JAMA | JAMA Network



Direct-to-Consumer Genetic TestingThe Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing

JAMA. Published online May 18, 2018. doi:10.1001/jama.2018.5330

No hay comentarios: